Estimation of insulin resistance in non-diabetic normotensive Saudi adults by QUICKI, HOMA-IR and modified QUICKI: A comparative study

Annals of Saudi Medicine

Volumn 30, Issue 4, 2010, Pages

  Bahijri, Suhad M ^a   Alissa, Eman M ^a   Akbar, Daad H ^a   Ghabrah, Tawfik M ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LIPID; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MODIFIED QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; OBESITY; PREVALENCE; PRIORITY JOURNAL; ADOLESCENT; BLOOD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; MIDDLE AGED; RISK FACTOR; SAUDI ARABIA; SEX DIFFERENCE; YOUNG ADULT;

ADIPOSITY; ADOLESCENT; ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FATTY ACIDS, NONESTERIFIED; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS; SAUDI ARABIA; SEX FACTORS; YOUNG ADULT;

EID: 77954976884     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.65252     Document Type: Article

References (41)

1. Caro JF. Clinical review 26. : Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 1991;73:691-696
2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1998;37:1595-1607
3. Banegas JR, López-García E, Graciani A, Guallar-Castillón P, Gutierrez-Fisac JL, Alonso J, et al. Relationship between obesity, hypertension and diabetes, and health-related quality of life among the elderly. Eur J Cardiovasc Prev Rehabil 2007;14:456-462
4. Preuss HG. Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence. J Am Coll Nutr 1997;16:397-403.
5. Day C. Metabolic syndrome or what you will: Definitions and epidemiology. Diab Vasc Dis Res 2007;4:32-38
6. World population prospects: the 2004 Review. Department of Economic and Social Affairs, Population Division: United Nations, New York; 2005.
7. Al Nuaim AR, Al-Mazrou Y, Al-Attas O, Al-Rubeaan K, Khoja T, Al-Daghari Ni. National chronic metabolic disease survey part I, prevalence diabetes mellitus, obesity and hyperlipidemia in Saudi Arabia. 1st ed. 1st ed. Riyadh (KSA): Ministry of Health; 1995. p. 1-75.
8. Mira SA, Akbar DH, Hashim IA, Salamah SH and Zawawi TH. The insulin resistance syndrome among type - 2 Saudi diabetics. Saudi Med J 2002;23:1045-1048
9. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS, Arafah MR, Khalil MZ, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004;25:1603-1610
10. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, et al. Insulin resistance and insulin secretory dysfunction as precursors of non- insulin- dependent diabetes mellitus: Prospective studies of Pima Indians. N Engl J Med 1993;329:1988-1992
11. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type II diabetes mellitus: Results of a 25- year follow- up study. Lancet 1992;340:925-929
12. Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: Effects of lifestyle intervention and metformin. Diabetes 2005;54:2404-2414
13. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, et al. Preservation of pancreatic cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002;51:2796-2803
14. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419
16. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410
17. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000;151:190-198
18. Abbasi F, Reaven GM. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 2002;51:235-237
19. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, et al. Repeatability characteristics of simple indices of insulin resistance: Implications for research applications. J Clin Endocrinol Metab 2001;86:5457-5464
20. Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 2001;86;4776-4781
21. Rabasa-Lhoret R, Bastard JP, Jan V, Ducluzeau PH, Andreelli F, Guebre F, et al. Modified quantitative insulin Sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab 2003;88:4917-4923
22. Al-Harithy RN, Al-Ghamdi S. Serum resistin, adiposity and insulin resistance in Saudi women with type2 diabetes mellitus. Ann Saudi Med 2005;25:283-287
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. , et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-1252
24. National cholesterol education program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-2497
25. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1999. Available from: http:// whqlibdoc.who.int/hq/1999/ WHO-NCD-NCS-99.2.pdf [last accessed on 2009 Sep 15].
26. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: WHO; 1998.
27. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Insulin resistance quantification by fasting insulin plasma values and HOMA index in non-diabetic population. Med Clin (Barc) 2001;117:530-533
28. Hrebícek J, Janout V, Malincíková J, Horáková D, Cízek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICK I for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002;87:144-147
29. AlSaif M, Hakim I, Harris R. Prevalence and risk factors of obesity and overweight in adult Saudi Population. Nutr Res 2002;22:1243-1252
30. al-Nuaim AR. Serum total and fractionated cholesterol distribution and prevalence of hypercholesterolemia in urban and rural communities in Saudi Arabia. Int J Cardiol 1997;58:141-149
31. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000;23:171-175
32. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of Cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006;29:1130-1139
33. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycemia: The current status on definition and intervention. Diabet Med 2002;19:708-723
34. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy: Validation studies in women with normal glucose tolerance and gestational diabetes. Diabetes Care 2001;24:1602-1607
35. Duncan GE, Hutson AD, Stacpoole PW. QUICKI is not a useful and accurate index of insulin sensitivity following training. J Clin Endocrinol Metab 2002;87:950-951
36. Stumvoll M, Wahl HG, Machicao F, Häring H. Insulin sensitivity of glucose disposal and lipolysis: No influence of common genetic variants in IRS-1 and CAPN10. Diabetologia 2002;45:651-656
37. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996;97:2859-2865
38. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, et al. Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 1989;84:205-213
39. Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 2002;40:937-943
40. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National heart, lung, and blood institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438
41. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985;248:E286-91.